EQUASENS Villers-lès-Nancy,
PRESS RELEASE
2021 first-quarter revenue:
+16.09% to €45.27m
- Robust growth in Q1, continuing the momentum of the prior quarters.
- Positive impact of acquisitions (+ €3.10m): PANDALAB integrated on 01/04/2020, ASCA INFORMATIQUE on 01/07/2020, PHARMAGEST SERVIZI (a new Italian subsidiary) on 01/02/2021.
- Like-for-like, Group revenue of €42.19m, up 8.19%.
- All Divisions contributed to growth.
- The Group is continuing to roll out new solutions to drive significant growth for its businesses and implement technologies to bridge the care pathway across the office-based private practice and hospital segments.
- The Group confirms its intention to pursue targeted acquisition opportunities in
France andEurope in 2021.
********
| (€m) | Q1 2021* | Q1 2020 | Change |
| Revenue | 45.27 | 39.00 | 16.09% |
* unaudited
At
Acquisitions (PANDALAB and ASCA INFORMATIQUE in 2020, and the recent creation of the Italian subsidiary PHARMAGEST SERVIZI) positively contributed to Q1 2021 revenue: + €3.10m. Like-for-like,
Operating highlights:
- The Pharmacy - Europe Solutions Division had revenue of €33.26m, up 17.37% in Q1 2020, bolstered by the contribution of ASCA INFORMATIQUE (+ €2.82m – integrated in
July 2020 ). Like-for-like, the Pharmacy France Business Unit grew 7.96%, in response to positive momentum from its new offerings (OffiLocker, etc.).
The Pharmacy Italy Business Unit registered strong growth in revenue of 17.64% benefiting in particular from the robust level of activity in the wholesalers-distributors market (notably with the development of DENSO and Check&Trace services), the deployment of Easy Pharma (the pharmacy management suite of the subsidiary SVEMU) and the launch of new solutions (EasyQ, SophiaUp, Miaterapia, etc.). In addition, a new subsidiary was created on
In
This Division accounts for 73.47% of total
- After a phase of significant external growth in 2019 and 2020 (acquisition of ICT, creation of
MALTA BELGIUM , acquisition of a majority stake in PANDALAB), the Health and Social Care Facilities (HSCF) Solutions Division consolidated its position with revenue of €6.95m in Q1, up 13.43%. Like-for-like, the Division’s revenue was up 9.93%.
All the Division’s business sectors contributed to this performance. The Senior Homes business line accordingly grew 4.71%, despite the slowdown experience in this market since 2020 in response to the health crisis. The Hospital business line grew 10.07%, benefiting from the resumption of investments in this sector. At the same time, the Hospital-at-Home and Healthcare Establishment and Private Practice business units registered particularly strong growth of respectively 19.81% and 53.09% from Q1 2020, reflecting notably ICT’s reorganisation and PANDALAB’s integration.
This Division accounts for 15.36% of total
- The e-Health Solutions Division had revenue of €4.40m, up 7.60% from Q1 2020.
The
This Division accounts for 9.73% of total
- The Fintech Division had revenue of €0.66m, up 50.04% benefiting from the strong growth of its network of new business introducers.
This Division accounts for 1.45% of total
Significant events occurring after
On 19 April, the Health and Social Care Facilities (HSCF) Solutions Division, managed by its subsidiary MALTA INFORMATIQUE, announced the completion of a strategic partnership with
This strategic partnership will accelerate the development in
Outlook
For 2021, given the strength of its business model, its integrated distribution network, the continuing development of innovative solutions to support and coordinate all functions within the medical ecosystem, the efforts of its teams and the loyalty of its customer base of healthcare professionals, Group management remains confident.
On that basis, the Group confirms its guidance for growth in revenue and reaffirms its strategy of continuing investments in innovation and targeted acquisitions in
In addition, France’s health sector reform (Ségur de la Santé) and its economic stimulus plan (“France Relance”) will accelerate investments in the digital transformation of the healthcare sector, including in the private practice segment (with a total budget of €19bn).
A key contributor to e-Health sector innovations in
Financial calendar:
- Annual General Meeting
29 June 2021 Pharmagest Group reminds readers that it will propose at the Annual General Meeting the payment of a dividend of €0.95 per share for fiscal 2020.- The General Meeting will be held at the registered office in Villers-lès-Nancy. In light of the current context, shareholders are invited to regularly consult the section devoted to the General Meeting on its website www.pharmagest.com - Finance/ General Meeting or information about procedures for participation.
- Publication of H1 2021 Revenue:
4 August 2021 .
- Publication of H1 2021 Results:
24 September 2021 .
About
With more than 1,100 employees acting as “Citizens in the Service of Health and Well-Being”,
As a key contributor to the quality of healthcare and coordination between office-based private practice and hospitals,
Listed on Euronext Paris™ - Compartment B
Indexes: MSCI GLOBAL SMALL CAP - GAÏA Index 2020 - CAC® SMALL and CAC® All-Tradable
Included under the European Rising Tech label.
Eligible for the “long-only” Deferred Settlement Service (“Service à Réglement Différé” - SRD) and equity savings accounts invested in small and mid caps (PEA-PME)
ISIN: FR 0012882389 – Reuters: PHA.PA – Bloomberg: PMGI FP
For all the latest news go to www.pharmagest.com
Follow
CONTACTS
Analyst and Investor Relations:
Chief Administrative and Financial Officer: Jean-Yves SAMSON
Tel. +33 (0)3 83 15 90 67 – jean-yves.samson@lacooperativewelcoop.com
Media Relations:
FIN’EXTENSO – Isabelle APRILE
Tel. +33 (0)1 39 97 61 22 - i.aprile@finextenso.fr
Attachment
- PHARMAGEST_PRESSRELEASE_20210512_SALES Q1 2021_EN
© OMX, source
